Veterinary clinical nutrition: success stories: an overview.
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
dietary management | neutral | chronic kidney disease | cats and dogs | - | reviewed include | #1 |
dietary modification | decrease | urinary tract uroliths | cats and dogs | - | dissolution | #2 |
taurine and L-carnitine deficiencies | increase | dilated cardiomyopathy | cats and dogs | - | can cause | #3 |
low-iodine diet | decrease | clinical signs associated with feline hyperthyroidism | cats | - | can be controlled | #4 |
dietary management | decrease | non-steroidal anti-inflammatory drug doses | canine osteoarthritis | - | can reduce | #5 |
diet | increase | disease-free intervals and survival times | dogs with Stage III lymphoma | - | can be statistically longer | #6 |
In this overview of success stories in veterinary clinical nutrition topics in cats and dogs reviewed include the dietary management of chronic kidney disease, dissolution of urinary tract uroliths by dietary modification, the recognition that taurine and L-carnitine deficiencies can cause dilated cardiomyopathy; that clinical signs associated with feline hyperthyroidism (caused by a benign adenoma) can be controlled by a low-iodine diet alone; that dietary management of canine osteoarthritis can also reduce non-steroidal anti-inflammatory drug doses; and that disease-free intervals and survival times can be statistically longer in dogs with Stage III lymphoma managed with diet. As we discover more about nutrigenetics and nutrigenomics, and as we expand our basic understanding of idiopathic diseases we are bound to identify more nutritionally related causes, and be able to develop novel dietary strategies to manage disease processes, including the formulation of diets designed to alter gene expression to obtain beneficial clinical outcomes.